Clinical Trial Update: Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating darolutamide with leuprolide acetate and exemestane in recurrent granulosa cell tumor of the ovary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulosa Cell Tumor of the Ovary

Drugs mentioned

• Darolutamide (darolutamide)
• Exemestane (Exemestane)
• Leuprolide acetate (Leuprolide acetate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Ovarian Granulosa Cell Tumor | Phase 2 | Status: ACTIVE_NOT_RECRUITING